Tampa, FLORIDA10 Active Studies

Osteogenesis Imperfecta Clinical Trials in Tampa, FLORIDA

Find 10 actively recruiting osteogenesis imperfecta clinical trials in Tampa, FLORIDA. Connect with local research sites and explore new treatment options.

10
Active Trials
10
Sponsors
2,285
Enrolling

Recruiting Osteogenesis Imperfecta Studies in Tampa

RecruitingTampa, FLORIDANCT06578247

Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML

This study will compare the effects of Quizartinib versus placebo in combination with chemotherapy in participants with newly diagnosed FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (I...

700 participants
Daiichi Sankyo
View Study Details
RecruitingTampa, FLORIDANCT06852222

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Acute Myeloid Leukemia (AML)

The purpose of this study is to assess how bleximenib and Venetoclax (VEN)+ Azacitidine (AZA) works as compared to placebo and VEN+AZA alone for the treatment of participants with Acute Myeloid Leukem...

600 participants
Janssen Research & Development, LLC
View Study Details
RecruitingTampa, FLORIDANCT04771130

A Study of BGB-11417 in Participants With Myeloid Malignancies

The study will determine the safety, tolerability, recommended Phase 2 dose (RP2D) and preliminary efficacy of BGB-11417 as monotherapy and in combination with azacitidine in participants with acute m...

260 participants
BeiGene
View Study Details
RecruitingTampa, FLORIDANCT06972446

A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

Rheumatoid Arthritis (RA) is a chronic inflammatory disease causing pain, stiffness, swelling and loss of joint function. This study will evaluate the efficacy and safety of targeted therapies through...

180 participants
AbbVie
View Study Details
RecruitingTampa, FLORIDANCT06969430

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

The primary purpose of Phase 1 is to assess the doses studied under Phase 1 (Dose Escalation) Arm A and identify the recommended dose (RD) for further development (Dose optimization). The primary obj...

134 participants
Debiopharm International SA
View Study Details
RecruitingTampa, FLORIDANCT06307613

A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease

This study aims to evaluate the efficacy, safety and tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of efgartigimod PH20 SC in participants with active, moderate-to-sev...

123 participants
argenx
View Study Details
RecruitingTampa, FLORIDANCT05972551

Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta

The primary objective of this study is to evaluate the effect of romosozumab treatment for 12-months compared with bisphosphonate(s) on the number of clinical fractures at 12-months; the number of any...

106 participants
Amgen
View Study Details
RecruitingTampa, FLORIDANCT06007690

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma

The primary objective is to determine the safety and efficacy of belzupacap sarotalocan (bel-sar) compared to sham control in patients with primary indeterminate lesions (IL) or small choroidal melano...

100 participants
Aura Biosciences
View Study Details
RecruitingTampa, FLORIDANCT06660368

BCL2i CLAG-M in R/R Acute Myeloid Leukemia

This multicenter, open-label phase II study combines CLAG-based therapy with or without venetoclax in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) in order to improve measur...

52 participants
H. Lee Moffitt Cancer Center and Research Institute
View Study Details
RecruitingTampa, FLORIDANCT05668962

Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC

This research is being done to determine the efficacy of selpercatinib to restore radioactive iodine (I-131 NaI) uptake and allow for I-131 treatment in people with RET fusion-positive radioiodine-ref...

30 participants
Massachusetts General Hospital
View Study Details

About Osteogenesis Imperfecta Clinical Trials in Tampa

Osteogenesis imperfecta is a group of genetic disorders mainly affecting the bones, causing them to break easily, often from little or no apparent cause. It is caused by defects in collagen production. Treatment includes bisphosphonates, physical therapy, and surgical rodding.

There are currently 10 osteogenesis imperfecta clinical trials recruiting participants in Tampa, FLORIDA. These studies are seeking a combined 2,285 participants. Research is being sponsored by Daiichi Sankyo, Janssen Research & Development, LLC, BeiGene and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Osteogenesis Imperfecta Clinical Trials in Tampa — FAQ

Are there osteogenesis imperfecta clinical trials in Tampa?

Yes, there are 10 osteogenesis imperfecta clinical trials currently recruiting in Tampa, FLORIDA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Tampa?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Tampa research site will contact you about next steps.

Are clinical trials in Tampa free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Tampa studies also compensate for your time and travel.

What osteogenesis imperfecta treatments are being tested?

The 10 active trials in Tampa are testing new therapies including novel drugs, biologics, and treatment approaches for osteogenesis imperfecta.

Data updated March 2, 2026 from ClinicalTrials.gov